Studies have shown that oroxylin A suppresses glycolysis in HCC and exerts anticancer effects by inhibiting the expression of downstream genes PDK1, LDHA, and HK II through the suppression of HIF-1α expression under hypoxic conditions (162). The gene discussed is HK2; the disease is hepatocellular carcinoma.